Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study

Bikdeli B. et al. [1] recently introduced the CORONA-VTE-Network study, an intended analysis of the adverse cardiovascular and thrombotic events in patients with COVID-19, distilling data from initial CORONA-VTE registry [2]. This large registry of 10,000 patients derived from prestigious healthcare institutions across the United States, is expected to shed light on key issues related to serious adverse outcomes of COVID-19 disease. As declared by these authors, investigators will systematically review and record detailed clinical and laboratory data from available patient electronic database systems to examine the rates of major cardiovascular complications as related to coronavirus-2 infection, antiviral or anti-inflammatory regimens, and the vaccination status.
Source: Thrombosis Research - Category: Hematology Authors: Tags: Letter to the Editors-in-Chief Source Type: research